• Medientyp: E-Artikel
  • Titel: Abstract TP203: Effect of SARS-CoV2 Infection on Endovascular Thrombectomy Outcomes - Data From the Florida Stroke Registry
  • Beteiligte: Fountain, Hayes B; Ramsay, Ian; Yin, Ruijie; Abdelsalam, Ahmed; Silva, Michael; Rose, David; Jameson, Angus; Alkhachroum, Ayham; Ying, Hao; Foster, Dianne; Gutierrez, Carolina M; Rundek, Tatjana; Romano, Jose G; Gardener, Hannah; Asdaghi, Negar; Starke, Robert M
  • Erschienen: Ovid Technologies (Wolters Kluwer Health), 2024
  • Erschienen in: Stroke
  • Sprache: Englisch
  • DOI: 10.1161/str.55.suppl_1.tp203
  • ISSN: 0039-2499; 1524-4628
  • Schlagwörter: Advanced and Specialized Nursing ; Cardiology and Cardiovascular Medicine ; Neurology (clinical)
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: <jats:p> <jats:bold>Introduction:</jats:bold> The outcomes of endovascular thrombectomy (EVT) in SARS-CoV2 positive patients with acute ischemic stroke (AIS) are not well studied. In the large Florida Stroke Registry we compared in hospital and discharge outcomes of patients with target vessel occlusions treated endovascularly with versus without a SARS-CoV2 positive infection status during their hospitalization. </jats:p> <jats:p> <jats:bold>Methods:</jats:bold> Data from Get With the Guidelines-Stroke hospitals participating in the Florida Stroke Registry from March 2020 to December 2022 were reviewed. EVT patients with coding for SARS-CoV2 testing during their hospital stay were categorized into SARS-CoV2 positive or negative groups. Associations between SARS-CoV2 status and favorable EVT outcomes of good mRS (0-2) at discharge, discharge to home or to rehabilitation centre, and independent ambulation at discharge were examined using multivariate logistic regression modeling adjusting for demographics, vascular risk factors, and clinical characteristics with generalized estimating equations (GEE). Temporal analyses compared outcomes across the years 2020-2022. </jats:p> <jats:p> <jats:bold>Results:</jats:bold> A total of 8,778 patients underwent EVT, of these, 193 (2.25%) were SARS-CoV2 positive. The odds of mRS 0-2 and independent ambulation at discharge were OR 0.194 (CI 0.035,1.077) and OR 0.794 (CI 0.168,3.75) in SARS-CoV2 positive relative to negative EVT patients. Outcomes of mRS 0-2 (OR 0.194, CI 0.035,1.077) and ambulation at discharge (OR 0.794, CI 0.168,3.75) were shy of statistical significance. Accounting for baseline differences SARS-CoV2 positive patients were less likely to be discharged home or to a rehabilitation centre (OR 0.671, CI 0.488,0.921) in multivariable analysis with GEE. Temporal analysis of SARS-CoV2 positive patients showed no significant differences across the years studied. </jats:p> <jats:p> <jats:bold>Conclusions:</jats:bold> In this large muliticentre stroke registry the results suggest that favorable outcomes post thrombectomy may be negatively impacted by SARS-CoV2 infection. Temporal assessment showed similar results across the years studied. These findings provide novel insight from a large database to add to the emerging literature examining outcomes of concurrent SARS-CoV2 infection in the setting of EVT for target vessel occlusion AIS. </jats:p>